CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 4 Shares withheld for taxes Executive President gave up 32,595 shares (to pay taxes)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $6.22 ($6,215)
- 4 Planned sale Chief Medical Officer sold 6,925 shares at $7.22 ($49,999)
- 4 Planned sale Chief Legal Officer sold 17,854 shares at $7.22 ($128,906)
- 4 Planned sale Chief Executive Officer sold 15,659 shares at $7.22 ($113,058)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,560 shares (to pay taxes)
- 4 Planned sale Chief Medical Officer sold 6,578 shares at $9.50 ($62,491)
- 4 Planned sale Chief Executive Officer sold 16,519 shares at $9.50 ($156,931)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 6,774 shares at $3.63 ($24,590)
Page 5 of 10 · 186 filings